"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 38 | 39 |
| 1997 | 1 | 29 | 30 |
| 1998 | 0 | 34 | 34 |
| 1999 | 2 | 31 | 33 |
| 2000 | 2 | 44 | 46 |
| 2001 | 1 | 22 | 23 |
| 2002 | 1 | 38 | 39 |
| 2003 | 3 | 39 | 42 |
| 2004 | 0 | 35 | 35 |
| 2005 | 2 | 33 | 35 |
| 2006 | 1 | 23 | 24 |
| 2007 | 1 | 17 | 18 |
| 2008 | 2 | 21 | 23 |
| 2009 | 0 | 19 | 19 |
| 2010 | 4 | 22 | 26 |
| 2011 | 1 | 22 | 23 |
| 2012 | 2 | 15 | 17 |
| 2013 | 2 | 22 | 24 |
| 2014 | 0 | 16 | 16 |
| 2015 | 4 | 16 | 20 |
| 2016 | 2 | 8 | 10 |
| 2017 | 2 | 11 | 13 |
| 2018 | 2 | 17 | 19 |
| 2019 | 0 | 10 | 10 |
| 2020 | 1 | 5 | 6 |
| 2021 | 1 | 13 | 14 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 4 | 4 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 2 | 2 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Controlled release of rhBMP-2 from nanoparticle-loaded biomimetic graft promotes bone regeneration in a rat spinal fusion model. Biomater Adv. 2026 Nov; 188:214989.
-
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines. J Virol. 2026 Jun 23; 100(6):e0031726.
-
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance). Cancer Immunol Res. 2026 Mar 04; 14(3):423-433.
-
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes. Eur J Endocrinol. 2025 Jul 31; 193(2):310-319.
-
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):299-307.
-
Homologous expression, purification, and characterization of a recombinant acetylxylan esterase from Aspergillus nidulans. Int J Biol Macromol. 2024 Nov; 280(Pt 2):135816.
-
Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia. J Stroke Cerebrovasc Dis. 2024 Jun; 33(6):107310.
-
Self-assembling amyloid-like nanostructures from SARS-CoV-2 S1, S2, RBD and N recombinant proteins. Arch Biochem Biophys. 2024 02; 752:109843.
-
Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion. J Neurosurg Spine. 2023 07 01; 39(1):113-121.
-
Acetylation of fission yeast tropomyosin does not promote differential association with cognate formins. Cytoskeleton (Hoboken). 2023 03; 80(3-4):77-92.